Human medicines
Recall of "EpiPen 300 micrograms solution for injection in a ready-to-use pen".
EpiPen recall 1
The marketing authorization holder informed its supplied customers in a letter dated March 23, 2017, that there is a very low probability that the…
Adalat
The marketing authorization holder has informed its supplied customers in a letter dated 22.2.2017 that a possible contamination with another active…
Kyprolis
The marketing authorization holder informed its supplied customers in a letter dated December 15, 2016, that the vials may have cracks in the glass.…
"Sertraline Sandoz" and "Lamotrigine Sandoz".
In a letter dated December 13, 2016, the marketing authorization holder informed its customers that the above-mentioned batches of "Sertraline Sandoz"…
Diamilla 75 microgram film-coated tablets
The marketing authorization holder informed its supplied customers in a letter dated October 12, 2016, that an impurity, "lmpurity D", was detected in…
Cycle ratiopharm 75 microgram film-coated tablets
The marketing authorization holder informed its supplied customers in a letter dated October 13, 2016, that an impurity, "lmpurity D", was detected…
Lisvy
Gedeon Richter Plc has informed their supplied customers by letter dated 12/10/2016 that above mentioned batches of "Lisvy 60 microgram/24 hours + 13…
Helixate NexGen
CSL Behring as distributor of the product Helixate NexGen has, in coordination with the marketing authorization holder Bayer Pharma AG, informed its…
Neoflubin
In a letter dated 19.09.2016, the marketing authorization holder informed its customers that yellow-brownish particles had been detected in the above…
